Seeing Is Believing
Healthcare - Sector
Sigilon Therapeutics's activity chart (see below) currently has 11 price targets and 12 ratings on display.
Analysts average stock forecasts to be materialized ratio is 63.33% with an average time for these price targets to be met of 139.5 days.
Most recent stock forecast was given by WHITNEY IJEM from CANACCORD on 05-Jul-2023. First documented stock forecast 29-Dec-2020.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 18-Jan-2023
$30
$7.53 (33.51%)
$6
3 years 3 months 26 days ago
(05-Jul-2023)
1/2 (50%)
$8.45 (39.21%)
127
Hold Since 30-Nov-2021
$21
$-1.47 (-6.54%)
$58.5
3 years 4 months 1 days ago
(30-Jun-2023)
1/2 (50%)
$-1.51 (-6.71%)
26
Buy Since 28-Oct-2021
$14
3 years 4 months 1 days ago
(30-Jun-2023)
2/2 (100%)
$-50.35 (-78.24%)
173
Buy Since 24-Dec-2021
$7
$-15.47 (-68.85%)
$91
4 years 10 months 3 days ago
(28-Dec-2021)
1/2 (50%)
$-28.1 (-80.06%)
268
Buy Since 29-Dec-2020
$91
$68.53 (304.98%)
$208
4 years 10 months 29 days ago
(02-Dec-2021)
1/3 (33.33%)
$50.7 (125.81%)
2
What is SGTX (Sigilon Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on SGTX (Sigilon Therapeutics)?
Which analyst has the most public recommendations on SGTX (Sigilon Therapeutics)?
Which analyst is the currently most bullish on SGTX (Sigilon Therapeutics)?
Which analyst is the currently most reserved on SGTX (Sigilon Therapeutics)?